Anti-Ehrlichia	B-protein
chaffeensis	I-protein
antibody	I-protein
complexed	O
with	O
E.	O
chaffeensis	O
induces	O
potent	O
proinflammatory	B-RNA
cytokine	I-RNA
mRNA	I-RNA
expression	O
in	O
human	B-cell_type
monocytes	I-cell_type
through	O
sustained	O
reduction	O
of	O
IkappaB-alpha	B-protein
and	O
activation	O
of	O
NF-kappaB	B-protein
.	O

Ehrlichia	O
chaffeensis	O
is	O
an	O
obligatory	O
intracellular	O
bacterium	O
that	O
infects	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
and	O
is	O
the	O
etiologic	O
agent	O
of	O
human	O
ehrlichiosis	O
in	O
the	O
United	O
States	O
.	O

Our	O
previous	O
studies	O
showed	O
that	O
the	O
exposure	O
of	O
human	B-cell_type
monocytes	I-cell_type
to	O
E.	O
chaffeensis	O
induces	O
the	O
expression	O
of	O
interleukin-1beta	B-protein
(	O
IL-1beta	B-protein
)	O
,	O
IL-8	B-protein
,	O
and	O
IL-10	B-DNA
genes	I-DNA
in	O
vitro	O
but	O
not	O
the	O
expression	O
of	O
tumor	B-RNA
necrosis	I-RNA
factor	I-RNA
alpha	I-RNA
(	I-RNA
TNF-alpha	I-RNA
)	I-RNA
and	I-RNA
IL-6	I-RNA
mRNAs	I-RNA
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
anti-E.	B-protein
chaffeensis	I-protein
antibody	I-protein
complexed	O
with	O
E.	O
chaffeensis	O
on	O
the	O
expression	O
of	O
major	B-protein
proinflammatory	I-protein
cytokines	I-protein
in	O
human	B-cell_type
monocytes	I-cell_type
was	O
examined	O
.	O

Human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
THP-1	I-cell_line
was	O
treated	O
with	O
E.	O
chaffeensis	O
which	O
had	O
been	O
preincubated	O
with	O
human	O
anti-E.	O
chaffeensis	O
serum	O
for	O
2	O
h	O
,	O
and	O
the	O
levels	O
of	O
cytokine	B-RNA
mRNAs	I-RNA
were	O
evaluated	O
by	O
competitive	O
reverse	O
transcription-PCR	O
.	O

Anti-E.	B-protein
chaffeensis	I-protein
antibody	I-protein
complexed	O
with	O
E.	O
chaffeensis	O
significantly	O
enhanced	O
mRNA	O
expression	O
of	O
IL-1beta	B-protein
in	O
THP-1	B-cell_line
cells	I-cell_line
.	O

The	O
expression	O
of	O
TNF-alpha	B-RNA
and	I-RNA
IL-6	I-RNA
mRNAs	I-RNA
was	O
also	O
induced	O
.	O

The	O
levels	O
of	O
secreted	O
IL-1beta	B-protein
,	O
TNF-alpha	B-protein
,	O
and	O
IL-6	B-protein
during	O
24	O
h	O
of	O
stimulation	O
were	O
comparable	O
to	O
those	O
induced	O
by	O
Escherichia	O
coli	O
lipopolysaccharide	O
at	O
1	O
microg/ml	O
.	O

Fab	O
fragment	O
of	O
anti-E.	B-protein
chaffeensis	I-protein
immunoglobulin	I-protein
G	I-protein
complexed	O
with	O
E.	O
chaffeensis	O
did	O
not	O
induce	O
any	O
of	O
these	O
three	O
cytokines	O
,	O
indicating	O
that	O
ehrlichial	O
binding	O
is	O
required	O
for	O
IL-1beta	B-RNA
mRNA	I-RNA
expression	O
and	O
that	O
binding	O
of	O
the	O
immune	B-protein
complex	I-protein
to	O
the	O
Fc	B-protein
gamma	I-protein
receptor	I-protein
is	O
required	O
for	O
TNF-alpha	B-protein
and	O
IL-6	B-RNA
mRNA	I-RNA
expression	O
and	O
enhanced	O
IL-1beta	B-RNA
mRNA	I-RNA
expression	O
.	O

Furthermore	O
,	O
prolonged	O
degradation	O
of	O
IkappaB-alpha	B-protein
and	O
activation	O
of	O
NF-kappaB	B-protein
were	O
demonstrated	O
in	O
THP-1	B-cell_line
cells	I-cell_line
exposed	O
to	O
anti-E.	O
chaffeensis	O
serum	O
and	O
E.	O
chaffeensis	O
.	O

This	O
result	O
implies	O
that	O
development	O
of	O
anti-E.	B-protein
chaffeensis	I-protein
antibody	I-protein
in	O
patients	O
can	O
result	O
in	O
the	O
production	O
of	O
major	B-protein
proinflammatory	I-protein
cytokines	I-protein
,	O
which	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathophysiology	O
of	O
ehrlichiosis	O
and	O
immune	O
responses	O
to	O
it	O
.	O

INFECTION	NULL
AND	NULL
ImMUNITY	NULL
,	NULL
July	NULL
1997	NULL
,	NULL
p.	NULL
2890-2897	NULL
0019-9567/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

65	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Anti-Ehrlichia	NULL
chaffeensis	NULL
Antibody	NULL
Complexed	NULL
with	NULL
E.	NULL
chaffeensis	NULL
Induces	NULL
Potent	NULL
Proinflammatory	NULL
Cytokine	NULL
mRNA	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
through	NULL
Sustained	NULL
Reduction	NULL
of	NULL
IxB-	NULL
«	NULL
and	NULL
Activation	NULL
of	NULL
NF-KB	NULL
EUNJOO	NULL
H.	NULL
LEE	NULL
anp	NULL
YASUKO	NULL
RIKIHISA	NULL
``	NULL
*	NULL
Molecular	NULL
,	NULL
Cellular	NULL
and	NULL
Developmental	NULL
Biology	NULL
Program	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Veterinary	NULL
Biosciences	NULL
,	NULL
``	NULL
Ohio	NULL
State	NULL
University	NULL
,	NULL
Columbus	NULL
,	NULL
Ohio	NULL
43210	NULL
Received	NULL
11	NULL
October	NULL
1996/Returned	NULL
for	NULL
modification	NULL
22	NULL
January	NULL
1997/Accepted	NULL
11	NULL
April	NULL
1997	NULL
Ehrlichia	NULL
chaffeensis	NULL
is	NULL
an	NULL
obligatory	NULL
intracellular	NULL
bacterium	NULL
that	NULL
infects	NULL
monocytes	NULL
and	NULL
macrophages	NULL
and	NULL
is	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
human	NULL
ehrlichiosis	NULL
in	NULL
the	NULL
United	NULL
States	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
showed	NULL
that	NULL
the	NULL
exposure	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
£	NULL
.	NULL

chaffeensis	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
interleukin-1B	NULL
(	NULL
IL-1B	NULL
)	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
IL-10	NULL
genes	NULL
in	NULL
vitro	NULL
but	NULL
not	NULL
the	NULL
expression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
LNF-a	NULL
«	NULL
)	NULL
and	NULL
IL-6	NULL
mRNAs	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
complexed	NULL
with	NULL
E.	NULL
chaffeensis	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
major	NULL
proinflammatory	NULL
cytokines	NULL
in	NULL
human	NULL
monocytes	NULL
was	NULL
examined	NULL
.	NULL

Human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
was	NULL
treated	NULL
with	NULL
£	NULL
.	NULL

chaffeensis	NULL
which	NULL
had	NULL
been	NULL
preincubated	NULL
with	NULL
human	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
for	NULL
2	NULL
h	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
cytokine	NULL
mRNAs	NULL
were	NULL
evaluated	NULL
by	NULL
competitive	NULL
reverse	NULL
transcription-PCR	NULL
.	NULL

Anti-	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
complexed	NULL
with	NULL
E.	NULL
chaffeensis	NULL
significantly	NULL
enhanced	NULL
mRNA	NULL
expression	NULL
of	NULL
IL-1f§	NULL
in	NULL
THP	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-6	NULL
mRNAs	NULL
was	NULL
also	NULL
induced	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
secreted	NULL
IL-1	NULL
$	NULL
,	NULL
TNF-a	NULL
@	NULL
,	NULL
and	NULL
IL-6	NULL
during	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
were	NULL
comparable	NULL
to	NULL
those	NULL
induced	NULL
by	NULL
Escherichia	NULL
coli	NULL
lipopolysaccharide	NULL
at	NULL
1	NULL
pg/ml	NULL
.	NULL

Fab	NULL
fragment	NULL
of	NULL
anti-E.	NULL
chaffeensis	NULL
immunoglobulin	NULL
G	NULL
complexed	NULL
with	NULL
E.	NULL
chaffeensis	NULL
did	NULL
not	NULL
induce	NULL
any	NULL
of	NULL
these	NULL
three	NULL
cytokines	NULL
,	NULL
indicating	NULL
that	NULL
ehrlichial	NULL
binding	NULL
is	NULL
required	NULL
for	NULL
IL-1B	NULL
mRNA	NULL
expression	NULL
and	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
immune	NULL
complex	NULL
to	NULL
the	NULL
Fey	NULL
receptor	NULL
is	NULL
required	NULL
for	NULL
TNF-a	NULL
and	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
and	NULL
enhanced	NULL
IL-1	NULL
mRNA	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
prolonged	NULL
degradation	NULL
of	NULL
IxB-	NULL
«	NULL
@	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
were	NULL
demonstrated	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
E.	NULL
chaffeensis	NULL
.	NULL

This	NULL
result	NULL
implies	NULL
that	NULL
development	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
in	NULL
patients	NULL
can	NULL
result	NULL
in	NULL
the	NULL
production	NULL
of	NULL
major	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
which	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
ehrlichiosis	NULL
and	NULL
immune	NULL
responses	NULL
to	NULL
it	NULL
.	NULL

Ehrlichia	NULL
chaffeensis	NULL
,	NULL
a	NULL
gram-negative	NULL
obligately	NULL
intracellular	NULL
bacterium	NULL
that	NULL
can	NULL
infect	NULL
monocytes	NULL
and	NULL
macrophages	NULL
(	NULL
32	NULL
)	NULL
,	NULL
is	NULL
recognized	NULL
as	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
human	NULL
monocytic	NULL
ehrlichiosis	NULL
in	NULL
the	NULL
United	NULL
States	NULL
(	NULL
1	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
discovery	NULL
of	NULL
the	NULL
disease	NULL
in	NULL
1986	NULL
,	NULL
more	NULL
than	NULL
400	NULL
cases	NULL
of	NULL
human	NULL
ehrlichiosis	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
30	NULL
states	NULL
in	NULL
the	NULL
United	NULL
States	NULL
(	NULL
14	NULL
)	NULL
.	NULL

A	NULL
PCR	NULL
assay	NULL
detected	NULL
E.	NULL
chaffeensis	NULL
DNA	NULL
in	NULL
the	NULL
Lone	NULL
Star	NULL
tick	NULL
,	NULL
Amblyomma	NULL
americanum	NULL
,	NULL
implying	NULL
that	NULL
this	NULL
tick	NULL
is	NULL
a	NULL
vector	NULL
of	NULL
the	NULL
disease	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Seven	NULL
to	NULL
nine	NULL
days	NULL
after	NULL
a	NULL
tick	NULL
bite	NULL
,	NULL
patients	NULL
develop	NULL
fever	NULL
,	NULL
headache	NULL
,	NULL
malaise	NULL
,	NULL
thrombocytopenia	NULL
,	NULL
leukope-nia	NULL
,	NULL
and	NULL
elevated	NULL
liver	NULL
enzyme	NULL
activities	NULL
and	NULL
C-reactive-protein	NULL
levels	NULL
(	NULL
16	NULL
)	NULL
.	NULL

These	NULL
clinical	NULL
signs	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
mediated	NULL
by	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
including	NULL
interleukin-1B	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
.	NULL

However	NULL
,	NULL
we	NULL
were	NULL
puzzled	NULL
,	NULL
since	NULL
our	NULL
previous	NULL
results	NULL
showed	NULL
that	NULL
£	NULL
.	NULL

chaffeensis	NULL
induces	NULL
IL-1B	NULL
but	NULL
not	NULL
TNF-	NULL
«	NULL
or	NULL
IL-6	NULL
in	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

E.	NULL
chaffeensis-infected	NULL
patients	NULL
develop	NULL
a	NULL
high	NULL
titer	NULL
of	NULL
antibody	NULL
;	NULL
therefore	NULL
,	NULL
a	NULL
serologic	NULL
test	NULL
has	NULL
been	NULL
used	NULL
as	NULL
the	NULL
primary	NULL
diagnostic	NULL
method	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Although	NULL
in	NULL
human	NULL
monocytic	NULL
ehrlichiosis	NULL
no	NULL
correlation	NULL
of	NULL
clinical	NULL
signs	NULL
and	NULL
antibody	NULL
development	NULL
has	NULL
been	NULL
reported	NULL
,	NULL
in	NULL
experimental	NULL
Ehrlichia	NULL
canis	NULL
infection	NULL
of	NULL
dogs	NULL
and	NULL
Ehrlichia	NULL
risticii	NULL
infection	NULL
of	NULL
horses	NULL
the	NULL
development	NULL
of	NULL
clinical	NULL
signs	NULL
coincides	NULL
with	NULL
formation	NULL
of	NULL
the	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Veterinary	NULL
Biosciences	NULL
,	NULL
College	NULL
of	NULL
Veterinary	NULL
Medicine	NULL
,	NULL
The	NULL
Ohio	NULL
State	NULL
University	NULL
,	NULL
1925	NULL
Coffey	NULL
Rd	NULL
.	NULL

,	NULL
Columbus	NULL
,	NULL
OH	NULL
43210-1093	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
614	NULL
)	NULL
292-5661	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
614	NULL
)	NULL
292-6473	NULL
.	NULL

2890	NULL
antibody	NULL
to	NULL
E.	NULL
canis	NULL
and	NULL
E.	NULL
risticii	NULL
,	NULL
respectively	NULL
(	NULL
20	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
Fc	NULL
receptors	NULL
on	NULL
monocytes	NULL
by	NULL
anti-Fc	NULL
receptor	NULL
antibody	NULL
or	NULL
immobilized	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
was	NULL
reported	NULL
to	NULL
induce	NULL
TNF-	NULL
«	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-8	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
13	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
26	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
complex	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
and	NULL
E.	NULL
chaffeensis	NULL
induces	NULL
a	NULL
strong	NULL
proinflammatory	NULL
cytokine	NULL
response	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
whether	NULL
this	NULL
response	NULL
is	NULL
mediated	NULL
through	NULL
Fey	NULL
receptors	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
cross-linking	NULL
Fc	NULL
receptors	NULL
induce	NULL
cytokines	NULL
in	NULL
monocytes	NULL
is	NULL
unknown	NULL
;	NULL
however	NULL
,	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
by	NULL
various	NULL
stimuli	NULL
,	NULL
including	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
10	NULL
,	NULL
18	NULL
,	NULL
23	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
further	NULL
examined	NULL
whether	NULL
the	NULL
complex	NULL
of	NULL
E.	NULL
chaffeensis	NULL
and	NULL
anti-E.	NULL
chaffeensis	NULL
antibody	NULL
induces	NULL
NF-kB	NULL
activation	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

This	NULL
study	NULL
revealed	NULL
an	NULL
important	NULL
new	NULL
role	NULL
of	NULL
antibody	NULL
for	NULL
host	NULL
defense	NULL
and	NULL
pathogenesis	NULL
during	NULL
intracellular	NULL
bacterial	NULL
infection	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
E.	NULL
chaffeensis	NULL
.	NULL

E.	NULL
chaffeensis	NULL
Arkansas	NULL
was	NULL
cultured	NULL
in	NULL
THP-1	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Atlanta	NULL
Biologicals	NULL
,	NULL
Norcross	NULL
,	NULL
Ga.	NULL
)	NULL
and	NULL
2	NULL
mM	NULL
1-Gin	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

When	NULL
more	NULL
than	NULL
90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
infected	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
examining	NULL
cells	NULL
stained	NULL
with	NULL
Diff-Quik	NULL
(	NULL
Baxter	NULL
Scientific	NULL
Products	NULL
,	NULL
Obetz	NULL
,	NULL
Ohio	NULL
)	NULL
,	NULL
the	NULL
infected	NULL
cells	NULL
were	NULL
sonicated	NULL
and	NULL
centrifuged	NULL
at	NULL
500	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
,	NULL
containing	NULL
host	NULL
cell-free	NULL
E.	NULL
chaffeensis	NULL
organisms	NULL
,	NULL
was	NULL
used	NULL
to	NULL
infect	NULL
THP-1	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
.	NULL

For	NULL
competitive	NULL
reverse	NULL
transcription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
analysis	NULL
,	NULL
10	NULL
``	NULL
THP-1	NULL
cells	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
medium	NULL
were	NULL
treated	NULL
with	NULL
each	NULL
stimulus	NULL
for	NULL
2	NULL
h	NULL
and	NULL
harvested	NULL
for	NULL
RNA	NULL
isolation	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
and	NULL
Western	NULL
immunoblot	NULL
assays	NULL
,	NULL
10°	NULL
cells	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
medium	NULL
were	NULL
incubated	NULL
with	NULL
each	NULL
stimulus	NULL
for	NULL
the	NULL
periods	NULL
indicated	NULL
in	NULL
the	NULL
figures	NULL
and	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
Vou	NULL
.	NULL

65	NULL
,	NULL
1997	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Human	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
J.	NULL
R.	NULL
Harkens	NULL
and	NULL
J.	NULL
Kudlak	NULL
of	NULL
the	NULL
Oklahoma	NULL
State	NULL
Department	NULL
of	NULL
Health	NULL
(	NULL
homologous-antibody	NULL
titer	NULL
=	NULL
1:640	NULL
by	NULL
the	NULL
indirect	NULL
fluorescent-antibody	NULL
[	NULL
IFA	NULL
]	NULL
test	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Dog	NULL
anti-Z	NULL
.	NULL

chaffeensis	NULL
serum	NULL
was	NULL
developed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
IFA	NULL
titer	NULL
=	NULL
1:5,120	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Normal	NULL
dog	NULL
serum	NULL
was	NULL
negative	NULL
for	NULL
£	NULL
.	NULL

chaffeensis	NULL
by	NULL
the	NULL
IFA	NULL
test	NULL
.	NULL

Normal	NULL
human	NULL
serum	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

and	NULL
negative	NULL
by	NULL
the	NULL
IFA	NULL
test	NULL
.	NULL

The	NULL
sera	NULL
were	NULL
preabsorbed	NULL
with	NULL
10°	NULL
uninfected	NULL
THP-1	NULL
cells	NULL
per	NULL
ml	NULL
by	NULL
incubation	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
used	NULL
at	NULL
0.2	NULL
ml	NULL
per	NULL
ml	NULL
of	NULL
incubation	NULL
medium	NULL
.	NULL

IgG	NULL
and	NULL
Fab	NULL
fragment	NULL
were	NULL
purified	NULL
from	NULL
preabsorbed	NULL
normal	NULL
or	NULL
dog	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
serum	NULL
by	NULL
using	NULL
an	NULL
ImmunoPure	NULL
Fab	NULL
preparation	NULL
kit	NULL
(	NULL
Pierce	NULL
Chemical	NULL
Co.	NULL
,	NULL
Rockford	NULL
,	NULL
IIL	NULL
.	NULL
)	NULL

and	NULL
used	NULL
at	NULL
0.1	NULL
mg	NULL
per	NULL
ml	NULL
of	NULL
incubation	NULL
medium	NULL
.	NULL

Preparation	NULL
of	NULL
Fab	NULL
fragments	NULL
was	NULL
confirmed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
immunofluorescence	NULL
microscopy	NULL
using	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
anti-dog	NULL
IgG	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Competitive	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
cells	NULL
by	NULL
the	NULL
guanidinium	NULL
thiocyanate	NULL
method	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
2	NULL
mg	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
in	NULL
a	NULL
30-pl	NULL
reaction	NULL
mixture	NULL
by	NULL
using	NULL
a	NULL
kit	NULL
(	NULL
first-strand	NULL
cDNA	NULL
synthesis	NULL
kit	NULL
;	NULL
Clontech	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
prepared	NULL
cDNA	NULL
(	NULL
1	NULL
to	NULL
2	NULL
pl	NULL
)	NULL
was	NULL
amplified	NULL
in	NULL
a	NULL
50-pl	NULL
reaction	NULL
mixture	NULL
.	NULL

Conditions	NULL
for	NULL
PCR	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
0.4	NULL
M	NULL
each	NULL
primer	NULL
,	NULL
0.2	NULL
mM	NULL
deoxynucleoside	NULL
triphosphate	NULL
mixture	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
2.0	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Primers	NULL
and	NULL
nonhomologous	NULL
internal	NULL
standards	NULL
(	NULL
PCR	NULL
MIMICs	NULL
)	NULL
for	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
and	NULL
primers	NULL
for	NULL
IL-6	NULL
were	NULL
purchased	NULL
from	NULL
Clontech	NULL
Laboratories	NULL
.	NULL

The	NULL
PCR	NULL
MIMIC	NULL
for	NULL
IL-6	NULL
was	NULL
constructed	NULL
by	NULL
using	NULL
a	NULL
PCR	NULL
MIMIC	NULL
construction	NULL
kit	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
MIMICs	NULL
added	NULL
to	NULL
the	NULL
PCR	NULL
mixtures	NULL
in	NULL
the	NULL
present	NULL
study	NULL
were	NULL
1	NULL
amol	NULL
for	NULL
IL-18	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
and	NULL
107	NULL
``	NULL
amol	NULL
for	NULL
IL-6	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
DNA	NULL
thermal	NULL
cycler	NULL
(	NULL
model	NULL
480	NULL
;	NULL
Perkin-Elmer	NULL
)	NULL
for	NULL
30	NULL
cycles	NULL
(	NULL
denaturation	NULL
at	NULL
94°C	NULL
for	NULL
45	NULL
s	NULL
,	NULL
annealing	NULL
at	NULL
60°C	NULL
for	NULL
45	NULL
s	NULL
,	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
}	NULL
.	NULL

Aliquots	NULL
of	NULL
reaction	NULL
products	NULL
were	NULL
electrophoresed	NULL
in	NULL
1.8	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
0.5	NULL
ug	NULL
of	NULL
ethidium	NULL
bromide	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
PCR	NULL
products	NULL
generated	NULL
by	NULL
the	NULL
target	NULL
and	NULL
competitive	NULL
internal	NULL
standard	NULL
were	NULL
analyzed	NULL
by	NULL
a	NULL
gel	NULL
video	NULL
system	NULL
(	NULL
Gel	NULL
Print	NULL
20001	NULL
;	NULL
BioPhotonics	NULL
Corp.	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
Mich.	NULL
)	NULL
and	NULL
image	NULL
analysis	NULL
software	NULL
(	NULL
ImageQuaNT	NULL
;	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
target	NULL
to	NULL
internal	NULL
standard	NULL
was	NULL
calculated	NULL
and	NULL
normalized	NULL
against	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
in	NULL
the	NULL
corresponding	NULL
sample	NULL
.	NULL

Nuclear-	NULL
and	NULL
cytoplasmic-extract	NULL
preparation	NULL
.	NULL

The	NULL
nuclear	NULL
extract	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
assay	NULL
and	NULL
the	NULL
cytoplasmic	NULL
extract	NULL
for	NULL
the	NULL
IxB-	NULL
«	NULL
Western	NULL
blot	NULL
assay	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
same	NULL
experimental	NULL
sample	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
after	NULL
the	NULL
treatment	NULL
described	NULL
above	NULL
,	NULL
cells	NULL
were	NULL
centrifuged	NULL
,	NULL
washed	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
and	NULL
then	NULL
suspended	NULL
in	NULL
400	NULL
pl	NULL
of	NULL
cold	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
wM	NULL
aprotinin	NULL
,	NULL
14	NULL
pM	NULL
leupeptin	NULL
,	NULL
1	NULL
wM	NULL
pepstatin	NULL
,	NULL
80	NULL
g	NULL
of	NULL
benzamidine	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

After	NULL
being	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
Nonidet	NULL
P-40	NULL
(	NULL
final	NULL
concentration	NULL
of	NULL
0.6	NULL
%	NULL
)	NULL
.	NULL

Lysis	NULL
was	NULL
completed	NULL
by	NULL
vigorous	NULL
vortexing	NULL
for	NULL
10	NULL
s.	NULL
The	NULL
homogenate	NULL
was	NULL
centrifuged	NULL
at	NULL
13,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
s	NULL
in	NULL
a	NULL
microcentrifuge	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
saved	NULL
for	NULL
cytoplasmic	NULL
extract	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
pellet	NULL
was	NULL
resus-pended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
cold	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
wM	NULL
aprotinin	NULL
,	NULL
14	NULL
M	NULL
leupeptin	NULL
,	NULL
1	NULL
M	NULL
pepstatin	NULL
,	NULL
80	NULL
jg	NULL
of	NULL
benzamidine	NULL
per	NULL
ml	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
13,000	NULL
x	NULL
g	NULL
for	NULL
30	NULL
s	NULL
,	NULL
the	NULL
resulting	NULL
supernatant	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
stored	NULL
in	NULL
small	NULL
aliquots	NULL
at	NULL
-80°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
reagent	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

The	NULL
NF-xB	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
22	NULL
bp	NULL
)	NULL
provided	NULL
in	NULL
the	NULL
kit	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
with	NULL
T4	NULL
nucleotide	NULL
kinase	NULL
,	NULL
and	NULL
100,000	NULL
cpm	NULL
of	NULL
the	NULL
probe	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
NF-kB	NULL
binding	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
for	NULL
DNA-protein	NULL
interaction	NULL
contained	NULL
2	NULL
pg	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-1	NULL
mM	NULL
MgCl1	NULL
,	NULL
-0.5	NULL
mM	NULL
EDTA-0.5	NULL
mM	NULL
dithiothreitol-50	NULL
mM	NULL
NaCl-0.05	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
pl	NULL
in	NULL
4	NULL
%	NULL
glycerol	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
25	NULL
pul	NULL
.	NULL

The	NULL
radioactive	NULL
DNA	NULL
probe	NULL
was	NULL
added	NULL
to	NULL
this	NULL
mixture	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
a	NULL
50-fold-excess	NULL
amount	NULL
of	NULL
unlabeled	NULL
SP1	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
22	NULL
bp	NULL
;	NULL
Promega	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
with	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
.	NULL

For	NULL
supershift	NULL
assay	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
rabbit	NULL
antibody	NULL
to	NULL
p50	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
)	NULL
or	NULL
rabbit	NULL
antibody	NULL
to	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
(	NULL
Rockland	NULL
,	NULL
Gilbertsville	NULL
,	NULL
Pa.	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
extracts	NULL
before	NULL
incubation	NULL
with	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
first	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
)	NULL
that	NULL
had	NULL
been	NULL
prerun	NULL
for	NULL
30	NULL
min	NULL
and	NULL
were	NULL
then	NULL
electrophoresed	NULL
at	NULL
100	NULL
V	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
an	NULL
X-ray	NULL
film	NULL
(	NULL
X-Omat	NULL
AR	NULL
;	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
N.Y.	NULL
)	NULL
at	NULL
-80°C	NULL
overnight	NULL
.	NULL

After	NULL
autoradiography	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
onto	NULL
a	NULL
piece	NULL
of	NULL
Whatman	NULL
3MM	NULL
paper	NULL
under	NULL
vacuum	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
2	NULL
h	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Western	NULL
immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
cytoplasmic	NULL
extracts	NULL
(	NULL
30	NULL
jg	NULL
each	NULL
)	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
were	NULL
fractionated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schlei-cher	NULL
&	NULL
Schuell	NULL
Inc.	NULL
,	NULL
Keene	NULL
,	NULL
N.H.	NULL
)	NULL
by	NULL
using	NULL
a	NULL
semidry	NULL
electroblotting	NULL
apparatus	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
overnight	NULL
in	NULL
Tween-phosphate-buffered	NULL
saline	NULL
(	NULL
PBS-	NULL
CYTOKINE	NULL
INDUCTION	NULL
BY	NULL
E.	NULL
CHAFFEENSIS	NULL
AND	NULL
ANTIBODY	NULL
-	NULL
2891	NULL
Tween	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
powder	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
rabbit	NULL
antiserum	NULL
to	NULL
IxB-	NULL
«	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
at	NULL
1	NULL
pg/ml	NULL
in	NULL
blocking	NULL
solution	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
45	NULL
min	NULL
and	NULL
washed	NULL
in	NULL
PBS-Tween	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Amersham	NULL
Life	NULL
Science	NULL
Inc.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IIL	NULL
.	NULL
)	NULL

in	NULL
blocking	NULL
solution	NULL
for	NULL
30	NULL
min	NULL
and	NULL
washed	NULL
in	NULL
PBS-Tween	NULL
.	NULL

The	NULL
antigen	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
Western	NULL
blotting	NULL
detection	NULL
system	NULL
according	NULL
to	NULL
the	NULL
procedure	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
same	NULL
membrane	NULL
was	NULL
reprobed	NULL
with	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
mouse	NULL
monoclonal	NULL
anti-	NULL
«	NULL
-tubulin	NULL
(	NULL
Cedarline	NULL
Lab	NULL
.	NULL

Limited	NULL
,	NULL
Hornby	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
)	NULL
to	NULL
detect	NULL
«	NULL
-tubulin	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Cytokine	NULL
assays	NULL
.	NULL

THP-1	NULL
cells	NULL
or	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
isolated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
12-well	NULL
culture	NULL
plates	NULL
with	NULL
each	NULL
stimulus	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
culture	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
each	NULL
cytokine	NULL
level	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
by	NULL
using	NULL
human	NULL
cytokine	NULL
immunoassay	NULL
kits	NULL
(	NULL
Quantikine	NULL
;	NULL
R	NULL
&	NULL
D	NULL
systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
Minn.	NULL
)	NULL
.	NULL

RESULTS	NULL
E.	NULL
chaffeensis	NULL
organisms	NULL
preincubated	NULL
with	NULL
human	NULL
or	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
induce	NULL
strong	NULL
TNF-a	NULL
@	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-1B	NULL
mRNA	NULL
expression	NULL
.	NULL

The	NULL
conditions	NULL
of	NULL
the	NULL
competitive	NULL
RT-PCR	NULL
were	NULL
optimized	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
22	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
THP	NULL
-1	NULL
cell	NULL
lysate	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
host	NULL
cell	NULL
substance	NULL
contamination	NULL
in	NULL
£	NULL
.	NULL

chaffeensis	NULL
preparation	NULL
had	NULL
no	NULL
influence	NULL
on	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
anti-£E	NULL
.	NULL

chaffeensis	NULL
serum	NULL
on	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
major	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
E.	NULL
chaffeensis	NULL
preincubated	NULL
with	NULL
me-dium	NULL
,	NULL
normal	NULL
human	NULL
serum	NULL
,	NULL
or	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
patient	NULL
serum	NULL
and	NULL
TNF-	NULL
«	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-18B	NULL
mRNA	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
competitive	NULL
RT-PCR	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
that	NULL
£	NULL
.	NULL

chaffeensis	NULL
preincubated	NULL
with	NULL
human	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
(	NULL
the	NULL
titer	NULL
of	NULL
immunofluorescent	NULL
antibody	NULL
against	NULL
E.	NULL
chaffeensis	NULL
was	NULL
1:640	NULL
)	NULL
induced	NULL
strong	NULL
TNF-	NULL
«	NULL
and	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
,	NULL
which	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
E.	NULL
chaffeensis	NULL
alone	NULL
or	NULL
with	NULL
normal	NULL
human	NULL
serum	NULL
.	NULL

IL-1B	NULL
mRNA	NULL
expression	NULL
by	NULL
E.	NULL
chaffeenis	NULL
was	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antiserum	NULL
but	NULL
not	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
normal	NULL
human	NULL
serum	NULL
(	NULL
about	NULL
fourfold	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
limited	NULL
availability	NULL
of	NULL
human	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
serum	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
(	NULL
the	NULL
titer	NULL
of	NULL
immunofluorescent	NULL
antibody	NULL
against	NULL
£	NULL
.	NULL

chaffeensis	NULL
was	NULL
1:5,120	NULL
)	NULL
has	NULL
a	NULL
effect	NULL
on	NULL
cytokine	NULL
mRNA	NULL
induction	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
human	NULL
antiserum	NULL
and	NULL
the	NULL
optimum	NULL
dosage	NULL
of	NULL
the	NULL
dog	NULL
immune	NULL
serum	NULL
in	NULL
inducing	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
dog	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
serum	NULL
also	NULL
strongly	NULL
induced	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
mRNA	NULL
expression	NULL
.	NULL

The	NULL
maximum	NULL
response	NULL
was	NULL
seen	NULL
with	NULL
a	NULL
10-fold	NULL
dilution	NULL
of	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
.	NULL

Cytokine	NULL
mRNA	NULL
expression	NULL
with	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Foy	NULL
receptor	NULL
.	NULL

Previously	NULL
,	NULL
cross-linking	NULL
of	NULL
Fey	NULL
receptors	NULL
with	NULL
anti-Fcey	NULL
receptor	NULL
monoclonal	NULL
antibody	NULL
was	NULL
reported	NULL
to	NULL
induce	NULL
IL-18	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
13	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
26	NULL
,	NULL
31	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
E.	NULL
risticii	NULL
complexed	NULL
with	NULL
anti-£	NULL
.	NULL

risficii	NULL
antibody	NULL
binds	NULL
to	NULL
P388D	NULL
,	NULL
macrophages	NULL
and	NULL
that	NULL
the	NULL
Fab	NULL
fragment	NULL
of	NULL
anti-£	NULL
.	NULL

risticii	NULL
IgG	NULL
blocks	NULL
ehrlichial	NULL
binding	NULL
to	NULL
either	NULL
ehrlichial	NULL
receptor	NULL
or	NULL
Fc	NULL
receptor	NULL
on	NULL
P388D	NULL
;	NULL
,	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
speculated	NULL
that	NULL
(	NULL
i	NULL
)	NULL
anti-E.	NULL
chaffeensis	NULL
antibody	NULL
bound	NULL
to	NULL
E.	NULL
chaffeensis	NULL
interacts	NULL
with	NULL
Fey	NULL
receptors	NULL
that	NULL
are	NULL
on	NULL
the	NULL
monocyte	NULL
surface	NULL
and	NULL
that	NULL
(	NULL
ii	NULL
)	NULL
this	NULL
interaction	NULL
is	NULL
responsible	NULL
for	NULL
IL-6	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
enhanced	NULL
IL-1B	NULL
mRNA	NULL
expression	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
E.	NULL
chaffeensis	NULL
preincubated	NULL
with	NULL
the	NULL
dog	NULL
immune	NULL
serum	NULL
,	NULL
IgG	NULL
,	NULL
or	NULL
Fab	NULL
fragment	NULL
purified	NULL
from	NULL
the	NULL
immune	NULL
serum	NULL
,	NULL
and	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
TNF-a	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-1B	NULL
mRNA	NULL
expression	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-E.	NULL
chaffeensis	NULL
IgG	NULL
was	NULL
as	NULL
high	NULL
as	NULL
that	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
E.	NULL
chaffeensis	NULL
prein-	NULL
2892	NULL
LEE	NULL
AND	NULL
RIKIHISA	NULL
A	NULL
IL-18	NULL
IL-6	NULL
TNF-a	NULL
G3PDH	NULL
XSA	NULL
ecesets	NULL
SSESS	NULL
8	NULL
eo	NULL
$	NULL
%	NULL
(	NULL
HEX	NULL
SARA	NULL
ee	NULL
<	NULL
%	NULL
%	NULL
ste	NULL
AXXXX	NULL
?	NULL

Meeeteteteted	NULL
Target/MIMIC	NULL
XC	NULL
Xx	NULL
e	NULL
SX	NULL
%	NULL
tare	NULL
!	NULL

w	NULL
,	NULL
%	NULL
%	NULL
&	NULL
%	NULL
e	NULL
3	NULL
0.0	NULL
sz	NULL
IL-6	NULL
0.5	NULL
|	NULL
Target/MIMIC	NULL
terete	NULL
!	NULL

00	NULL
it	NULL
a	NULL
%	NULL
GG	NULL
&	NULL
$	NULL
6	NULL
2	NULL
%	NULL
2x	NULL
SCHH	NULL
SSX	NULL
iet	NULL
(	NULL
%	NULL
6	NULL
&	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
InFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

:	NULL
-	NULL
E.chaffeensis	NULL
-	NULL
Target	NULL
(	NULL
802	NULL
bp	NULL
)	NULL
-	NULL
MIMIC	NULL
(	NULL
630	NULL
bp	NULL
)	NULL
-	NULL
Target	NULL
(	NULL
628	NULL
bp	NULL
)	NULL
-	NULL
MIMIC	NULL
(	NULL
479	NULL
bp	NULL
)	NULL
-	NULL
MIMIC	NULL
(	NULL
617	NULL
bp	NULL
)	NULL
-	NULL
Target	NULL
(	NULL
444	NULL
bp	NULL
)	NULL
-	NULL
Target	NULL
(	NULL
983	NULL
bp	NULL
)	NULL
-	NULL
MIMIC	NULL
(	NULL
630	NULL
bp	NULL
)	NULL
5	NULL
6	NULL
4	NULL
TNF	NULL
-x	NULL
3	NULL
|-2	NULL
|-1	NULL
|-0	NULL
soon	NULL
raraeral	NULL
2	NULL
XXX	NULL
v	NULL
q	NULL
s	NULL
%	NULL
EX	NULL
'	NULL
A	NULL
(	NULL
{	NULL
=	NULL
(	NULL
XES	NULL
3	NULL
3	NULL
|-	NULL
(	NULL
EXCH	NULL
'	NULL
|-	NULL
(	NULL
NXS	NULL
-	NULL
(	NULL
CXX	NULL
1	NULL
|-	NULL
'	NULL
10	NULL
-	NULL
(	NULL
XXXS	NULL
INCH	NULL
-	NULL
[	NULL
XXCH	NULL
bte	NULL
IR	NULL
te	NULL
RKC	NULL
4	NULL
IRR	NULL
g	NULL
IRR	NULL
#	NULL
KSCS	NULL
-	NULL
KXxe	NULL
e	NULL
REEN	NULL
-	NULL
Kxx	NULL
d	NULL
-	NULL
RXXK	NULL
eee	NULL
ste	NULL
RSS	NULL
Re	NULL
BeE	NULL
Pesce	NULL
RS	NULL
o	NULL
)	NULL
xsd	NULL
(	NULL
XXSS	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
human	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
on	NULL
mRNA	NULL
expression	NULL
of	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
E.	NULL
chaffeensis	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Medium	NULL
alone	NULL
,	NULL
normal	NULL
human	NULL
serum	NULL
,	NULL
and	NULL
human	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
serum	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
or	NULL
without	NULL
host	NULL
cell-free	NULL
£	NULL
.	NULL

chaffeensis	NULL
and	NULL
added	NULL
to	NULL
THP-1	NULL
cells	NULL
.	NULL

After	NULL
2	NULL
h	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
subjected	NULL
to	NULL
competitive	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
constant	NULL
amount	NULL
of	NULL
the	NULL
PCR	NULL
MIMIC	NULL
was	NULL
coamplified	NULL
with	NULL
cDNA	NULL
,	NULL
and	NULL
then	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
1.8	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
that	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
gel	NULL
video	NULL
system	NULL
with	NULL
image	NULL
analysis	NULL
software	NULL
,	NULL
and	NULL
the	NULL
ratios	NULL
of	NULL
targets	NULL
to	NULL
MIMICs	NULL
are	NULL
shown	NULL
in	NULL
the	NULL
graph	NULL
.	NULL

G3PDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
.	NULL

cubated	NULL
with	NULL
the	NULL
Fab	NULL
fragment	NULL
of	NULL
the	NULL
immune	NULL
IgG	NULL
did	NULL
not	NULL
induce	NULL
any	NULL
of	NULL
three	NULL
cytokines	NULL
examined	NULL
.	NULL

This	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
blockage	NULL
of	NULL
binding	NULL
of	NULL
the	NULL
ehrlichial	NULL
carbohydrate	NULL
compo-nent	NULL
,	NULL
which	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
IL-1	NULL
induction	NULL
(	NULL
22	NULL
)	NULL
by	NULL
the	NULL
Fab	NULL
fragment	NULL
of	NULL
anti-E.	NULL
chaffeensis	NULL
antibody	NULL
.	NULL

IL-18B	NULL
mRNA	NULL
induction	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-E.	NULL
chaffeensis	NULL
anti-body	NULL
,	NULL
therefore	NULL
,	NULL
most	NULL
likely	NULL
occurs	NULL
independently	NULL
from	NULL
the	NULL
receptor	NULL
(	NULL
s	NULL
)	NULL
for	NULL
the	NULL
ehrlichial	NULL
carbohydrate	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
interaction	NULL
of	NULL
anti-Ehrlichia	NULL
IgG	NULL
with	NULL
Foy	NULL
receptors	NULL
on	NULL
monocytes	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-6	NULL
mRNA	NULL
and	NULL
for	NULL
enhanced	NULL
IL-18	NULL
mRNA	NULL
expression	NULL
.	NULL

Secretion	NULL
of	NULL
IL-1	NULL
$	NULL
B	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
@	NULL
by	NULL
THP-1	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
protein	NULL
synthesis	NULL
and	NULL
secretion	NULL
of	NULL
cytokines	NULL
,	NULL
we	NULL
determined	NULL
cytokine	NULL
levels	NULL
secreted	NULL
by	NULL
THP-1	NULL
cells	NULL
by	NULL
capture	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
normal	NULL
serum	NULL
did	NULL
not	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
E.	NULL
chaffeensis-mediated	NULL
secretion	NULL
of	NULL
IL-18B	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

The	NULL
immune	NULL
serum	NULL
induced	NULL
secretion	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-6	NULL
in	NULL
THP	NULL
cells	NULL
in	NULL
&	NULL
rel	NULL
©	NULL
y	NULL
A	NULL
O	NULL
&	NULL
m	NULL
8	NULL
w	NULL
so	NULL
pau	NULL
f	NULL
Ia	NULL
S	NULL
)	NULL
e	NULL
m	NULL
&	NULL
&	NULL
2	NULL
a	NULL
§	NULL
#	NULL
a	NULL
qo	NULL
$	NULL
%	NULL
§	NULL
-	NULL
s2	NULL
3	NULL
8	NULL
30	NULL
4	NULL
.0	NULL
&	NULL
g	NULL
#	NULL
3	NULL
a	NULL
a	NULL
m	NULL
&	NULL
A	NULL
a-	NULL
$	NULL
8	NULL
U	NULL
ac	NULL
E	NULL
se	NULL
kk	NULL
a+	NULL
mm	NULL
y	NULL
Em	NULL
va	NULL
Z	NULL
o	NULL
+00	NULL
To	NULL
+	NULL
E	NULL
U	NULL
2	NULL
o	NULL
m	NULL
+	NULL
30+	NULL
2	NULL
s	NULL
+	NULL
=o	NULL
+	NULL
3	NULL
5	NULL
a	NULL
nt	NULL
+	NULL
-=	NULL
+	NULL
Na	NULL
0	NULL
+	NULL
A	NULL
IL-18	NULL
Vou	NULL
.	NULL

65	NULL
,	NULL
1997	NULL
a	NULL
a	NULL
A.	NULL
g..o	NULL
5	NULL
or	NULL
co	NULL
t=	NULL
ay	NULL
w/	NULL
mm	NULL
E	NULL
tod	NULL
IL-6	NULL
--	NULL
MIMIC	NULL
(	NULL
617	NULL
bp	NULL
)	NULL
-	NULL
Target	NULL
(	NULL
444	NULL
bp	NULL
)	NULL
-C	NULL
-	NULL
Target	NULL
(	NULL
983	NULL
bp	NULL
)	NULL
-	NULL
MIMIC	NULL
(	NULL
630	NULL
bp	NULL
)	NULL
a=	NULL
]	NULL
A	NULL
Aa	NULL
n	NULL
O	NULL
ereverereterererevere	NULL
ERAS	NULL
Nereo	NULL
eee	NULL
eter	NULL
nese	NULL
esc	NULL
)	NULL
Rinn	NULL
Ae	NULL
(	NULL
TE	NULL
Ne	NULL
NTIA	NULL
Sst	NULL
see	NULL
ece	NULL
ee	NULL
oce	NULL
nese	NULL
oce	NULL
ocececacoce	NULL
acocececact	NULL
EAA	NULL
AAA	NULL
AXA	NULL
AAA	NULL
XAX	NULL
AA	NULL
AX	NULL
Mre	NULL
ere	NULL
neeson	NULL
enone	NULL
S	NULL
HC	NULL
3	NULL
ERS	NULL
Pr	NULL
e	NULL
20000	NULL
0000000005	NULL
T	NULL
[	NULL
aa	NULL
]	NULL
nas	NULL
:	NULL
lle	NULL
a	NULL
aas	NULL
4	NULL
C	NULL
|	NULL
(	NULL
5	NULL
I	NULL
-	NULL
0	NULL
~	NULL
«	NULL
-	NULL
o	NULL
EX	NULL
Ea	NULL
Eanes	NULL
8	NULL
Le	NULL
EXAXAXXAXAX	NULL
A	NULL
pps	NULL
BSP	NULL
ARe	NULL
N20	NULL
eS	NULL
SA	NULL
1505005000000	NULL
x=	NULL
«	NULL
&	NULL
1	NULL
I	NULL
LI	NULL
IL	NULL
1	NULL
I	NULL
-	NULL
00	NULL
u	NULL
o	NULL
«	NULL
-	NULL
O	NULL
O	NULL
oliwninnebuei	NULL
oininnoBier	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
on	NULL
expression	NULL
of	NULL
IL-18	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
mRNA	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
£	NULL
.	NULL

chaffeensis	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Host	NULL
cell-free	NULL
E.	NULL
chaffeensis	NULL
organisms	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
or	NULL
different	NULL
dilutions	NULL
of	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
added	NULL
to	NULL
THP-1	NULL
cells	NULL
.	NULL

After	NULL
2	NULL
h	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
constant	NULL
amount	NULL
of	NULL
the	NULL
PCR	NULL
MIMIC	NULL
was	NULL
coamplified	NULL
with	NULL
cDNA	NULL
,	NULL
and	NULL
then	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
1.8	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
gel	NULL
video	NULL
system	NULL
with	NULL
image	NULL
analysis	NULL
software	NULL
,	NULL
and	NULL
the	NULL
ratios	NULL
of	NULL
targets	NULL
to	NULL
MIMICs	NULL
are	NULL
shown	NULL
.	NULL

G3PDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
.	NULL

shown	NULL
above	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
normal	NULL
hu-	NULL
the	NULL
presence	NULL
of	NULL
E.	NULL
chaffeensis	NULL
.	NULL

The	NULL
secretion	NULL
of	NULL
IL-1B	NULL
was	NULL
also	NULL
man	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
support	NULL
ing	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
THP-1	NULL
cells	NULL
.	NULL

enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
immune	NULL
serum	NULL
.	NULL

Anti-£	NULL
.	NULL

Prolonged	NULL
NF-KB	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
cytokine	NULL
gene	NULL
chaffeensis	NULL
IgG	NULL
had	NULL
similar	NULL
effects	NULL
on	NULL
cytokine	NULL
secretion	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
secreted	NULL
cytokines	NULL
in	NULL
cells	NULL
stimulated	NULL
by	NULL
immune	NULL
serum	NULL
or	NULL
the	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
IgG	NULL
were	NULL
comparable	NULL
to	NULL
those	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
£	NULL
.	NULL

chaffeensis	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
consists	NULL
of	NULL
a	NULL
expression	NULL
in	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
E.	NULL
coli	NULL
LPS	NULL
.	NULL

However	NULL
,	NULL
immune	NULL
Fab	NULL
fragment	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
secretion	NULL
of	NULL
any	NULL
of	NULL
these	NULL
cyto-	NULL
family	NULL
of	NULL
dimeric	NULL
factors	NULL
and	NULL
is	NULL
known	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
many	NULL
cytokine	NULL
genes	NULL
,	NULL
kines	NULL
.	NULL

These	NULL
results	NULL
corresponded	NULL
with	NULL
the	NULL
RT-PCR	NULL
results	NULL
2894	NULL
LEE	NULL
AND	NULL
RIKIHISA	NULL
Normal	NULL
serum	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
TNF-a	NULL
G3PDH	NULL
InFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

Immune	NULL
serum	NULL
Target	NULL
(	NULL
802	NULL
bp	NULL
)	NULL
MIMIC	NULL
(	NULL
630	NULL
bp	NULL
)	NULL
Target	NULL
(	NULL
628	NULL
bp	NULL
)	NULL
MIMIC	NULL
(	NULL
479	NULL
bp	NULL
)	NULL
MIMIC	NULL
(	NULL
617	NULL
bp	NULL
)	NULL
Target	NULL
(	NULL
444	NULL
bp	NULL
)	NULL
Target	NULL
(	NULL
983	NULL
bp	NULL
)	NULL
MIMIC	NULL
(	NULL
630	NULL
bp	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
IgG	NULL
or	NULL
the	NULL
Fab	NULL
fragment	NULL
of	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
on	NULL
mRNA	NULL
expression	NULL
of	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
E.	NULL
chaffeensis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
THP-1	NULL
cells	NULL
treated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
medium	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
serum	NULL
(	NULL
dilution	NULL
,	NULL
1/10	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
IgG	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
Fab	NULL
fragment	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
medium	NULL
plus	NULL
E.	NULL
chaffeensis	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
serum	NULL
plus	NULL
E.	NULL
chaffeensis	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
IgG	NULL
plus	NULL
E.	NULL
chaffeensis	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
Fab	NULL
fragment	NULL
plus	NULL
E.	NULL
chaffeensis	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
constant	NULL
amount	NULL
of	NULL
the	NULL
PCR	NULL
MIMIC	NULL
was	NULL
coamplified	NULL
with	NULL
cDNA	NULL
,	NULL
and	NULL
then	NULL
the	NULL
PCR	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
1.8	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

G3PDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
.	NULL

including	NULL
those	NULL
for	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
TNF-a	NULL
«	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
by	NULL
extracellular	NULL
signals	NULL
such	NULL
as	NULL
LPS	NULL
(	NULL
4	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
heterodimer	NULL
p65/p50	NULL
is	NULL
the	NULL
prototyp-ical	NULL
and	NULL
most	NULL
abundant	NULL
form	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
various	NULL
immune	NULL
and	NULL
inflammatory	NULL
genes	NULL
,	NULL
while	NULL
the	NULL
homodimer	NULL
p50/p50	NULL
is	NULL
constitutively	NULL
present	NULL
(	NULL
4	NULL
,	NULL
10	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
NF-KB	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
cytokine	NULL
induction	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
E.	NULL
chaffeensis	NULL
.	NULL

In	NULL
cells	NULL
exposed	NULL
to	NULL
E.	NULL
chaffeensis	NULL
only	NULL
,	NULL
NF-kB	NULL
(	NULL
p65/p50	NULL
)	NULL
activation	NULL
peaked	NULL
at	NULL
30	NULL
min	NULL
postincubation	NULL
and	NULL
decreased	NULL
thereafter	NULL
back	NULL
to	NULL
the	NULL
control	NULL
level	NULL
at	NULL
4	NULL
h.	NULL
In	NULL
cells	NULL
exposed	NULL
to	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
E.	NULL
chaffeensis	NULL
,	NULL
NF-kB	NULL
(	NULL
p65/p50	NULL
)	NULL
activation	NULL
peaked	NULL
at	NULL
2	NULL
h	NULL
and	NULL
lasted	NULL
for	NULL
up	NULL
to	NULL
8	NULL
h	NULL
postincubation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Quantitation	NULL
results	NULL
of	NULL
p65/p50	NULL
complexes	NULL
confirmed	NULL
that	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
£	NULL
.	NULL

chaffeensis	NULL
induced	NULL
stronger	NULL
and	NULL
more	NULL
prolonged	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
THP-1	NULL
cells	NULL
than	NULL
£	NULL
.	NULL

chaffeensis	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
NF-KB	NULL
activity	NULL
was	NULL
composed	NULL
of	NULL
p65/p50	NULL
heterodimer	NULL
,	NULL
as	NULL
confirmed	NULL
by	NULL
supershift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

The	NULL
faster-migrating	NULL
complex	NULL
constitutively	NULL
present	NULL
in	NULL
both	NULL
unstimulated	NULL
and	NULL
stimulated	NULL
cells	NULL
was	NULL
composed	NULL
of	NULL
p50/	NULL
p50	NULL
homodimers	NULL
,	NULL
as	NULL
confirmed	NULL
by	NULL
supershifting	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
8	NULL
TABLE	NULL
1	NULL
.	NULL

Secretion	NULL
of	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
«	NULL
by	NULL
THP-1	NULL
cells	NULL
infected	NULL
with	NULL
E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
``	NULL
Conen	NULL
(	NULL
pg/ml	NULL
)	NULL
Treatment	NULL
IL-1B	NULL
IL-6	NULL
TNF-	NULL
«	NULL
Medium	NULL
alone	NULL
<	NULL
0.3	NULL
<	NULL
0.7	NULL
<	NULL
4.4	NULL
Medium	NULL
+	NULL
£	NULL
.	NULL

chaffeensis	NULL
330	NULL
+	NULL
21	NULL
<	NULL
0.7	NULL
6	NULL
+3	NULL
Medium	NULL
+	NULL
E.	NULL
colf	NULL
LPS	NULL
836	NULL
+17	NULL
675	NULL
+	NULL
105	NULL
_	NULL
2,924	NULL
+	NULL
668	NULL
Normal	NULL
serum	NULL
+	NULL
medium	NULL
<	NULL
0.3	NULL
<	NULL
0.7	NULL
<	NULL
4.4	NULL
Normal	NULL
serum	NULL
+	NULL
£	NULL
.	NULL

chaffeensis	NULL
339	NULL
+	NULL
33	NULL
<	NULL
0.7	NULL
8	NULL
+3	NULL
Immune	NULL
serum	NULL
+	NULL
medium	NULL
<	NULL
0.3	NULL
<	NULL
0.7	NULL
9	NULL
+	NULL
2	NULL
Immune	NULL
serum	NULL
+	NULL
£	NULL
.	NULL

chaffeensis	NULL
_	NULL
728	NULL
+	NULL
159	NULL
597	NULL
+	NULL
73	NULL
2,982	NULL
+	NULL
140	NULL
Immune	NULL
IgG	NULL
+	NULL
medium	NULL
<	NULL
0.3	NULL
<	NULL
0.7	NULL
<	NULL
4.4	NULL
Immune	NULL
IgG	NULL
+	NULL
£	NULL
.	NULL

chaffeensis	NULL
754	NULL
+	NULL
44	NULL
675	NULL
+120	NULL
_	NULL
2,778	NULL
+	NULL
174	NULL
Immune	NULL
Fab	NULL
+	NULL
medium	NULL
<	NULL
0.3	NULL
<	NULL
0.7	NULL
<	NULL
4.4	NULL
Immune	NULL
Fab	NULL
+	NULL
£	NULL
.	NULL

chaffeensis	NULL
13	NULL
+	NULL
2	NULL
<	NULL
0.7	NULL
5	NULL
+3	NULL
``	NULL
Cytokine	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
capture	NULL
ELISA	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
)	NULL
.	NULL

The	NULL
detection	NULL
limits	NULL
of	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
were	NULL
0.3	NULL
,	NULL
0.7	NULL
,	NULL
and	NULL
4.4	NULL
pg/ml	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
deviations	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

and	NULL
9	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
NF-kB	NULL
complexes	NULL
to	NULL
the	NULL
NF-kB	NULL
consensus	NULL
oligonucleotide	NULL
was	NULL
specific	NULL
,	NULL
since	NULL
it	NULL
was	NULL
competitively	NULL
inhibited	NULL
by	NULL
the	NULL
nonlabeled	NULL
specific	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
not	NULL
by	NULL
a	NULL
nonspecific	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

IrB-a	NULL
«	NULL
degradation	NULL
correlates	NULL
with	NULL
NF-B	NULL
activation	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
E.	NULL
chaffeensis	NULL
.	NULL

IxB-a	NULL
«	NULL
is	NULL
a	NULL
cytoplasmic	NULL
protein	NULL
(	NULL
37	NULL
kDa	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
NF-kB	NULL
and	NULL
inhibits	NULL
the	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
its	NULL
cognate	NULL
binding	NULL
site	NULL
by	NULL
masking	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-kB	NULL
(	NULL
3	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Upon	NULL
activation	NULL
of	NULL
cells	NULL
with	NULL
various	NULL
extracellular	NULL
signals	NULL
such	NULL
as	NULL
LPS	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
IL-1	NULL
,	NULL
or	NULL
TNF-a	NULL
,	NULL
IxB-a	NULL
«	NULL
is	NULL
rapidly	NULL
degraded	NULL
,	NULL
allowing	NULL
NF-kB	NULL
to	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
bind	NULL
to	NULL
an	NULL
NF-	NULL
«	NULL
B-responsive	NULL
DNA	NULL
element	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
changes	NULL
in	NULL
cytoplasmic	NULL
IxB-	NULL
«	NULL
protein	NULL
levels	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
to	NULL
determine	NULL
whether	NULL
IxB-	NULL
«	NULL
degradation	NULL
correlates	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
transient	NULL
IxB-	NULL
«	NULL
degradation	NULL
was	NULL
demonstrated	NULL
at	NULL
15	NULL
min	NULL
to	NULL
1	NULL
h	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
£	NULL
.	NULL

chaffeensis	NULL
alone	NULL
.	NULL

In	NULL
cells	NULL
exposed	NULL
to	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
and	NULL
E.	NULL
chaffeensis	NULL
,	NULL
prolonged	NULL
IxB-	NULL
«	NULL
degradation	NULL
was	NULL
observed	NULL
for	NULL
up	NULL
to	NULL
4	NULL
h	NULL
,	NULL
which	NULL
generally	NULL
corresponds	NULL
to	NULL
prolonged	NULL
NF-kB	NULL
activation	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
demonstrated	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
that	NULL
antibody	NULL
complexed	NULL
with	NULL
bacteria	NULL
is	NULL
responsible	NULL
for	NULL
proinflammatory	NULL
cytokine	NULL
production	NULL
.	NULL

Monocytic	NULL
Ehrlichia	NULL
spp	NULL
.	NULL

induce	NULL
a	NULL
strong	NULL
antibody	NULL
response	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Antibody	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
TABLE	NULL
2	NULL
.	NULL

Secretion	NULL
of	NULL
IL-6	NULL
and	NULL
TNF-	NULL
«	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
infected	NULL
with	NULL
E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
``	NULL
Conen	NULL
(	NULL
pg/ml	NULL
)	NULL
Treatment	NULL
IL-6	NULL
TNF-a	NULL
Medium	NULL
alone	NULL
<	NULL
0.7	NULL
44	NULL
+	NULL
2.7	NULL
Medium	NULL
+	NULL
E.	NULL
chaffeensis	NULL
<	NULL
0.7	NULL
45	NULL
+	NULL
4.2	NULL
Medium	NULL
+	NULL
£	NULL
.	NULL

coli	NULL
LPS	NULL
746	NULL
+	NULL
89	NULL
2,601	NULL
+	NULL
180	NULL
Normal	NULL
serum	NULL
+	NULL
medium	NULL
<	NULL
0.7	NULL
40	NULL
+	NULL
4.2	NULL
Normal	NULL
serum	NULL
+	NULL
E.	NULL
chaffeensis	NULL
<	NULL
0.7	NULL
51	NULL
+	NULL
4.2	NULL
Immune	NULL
serum	NULL
+	NULL
medium	NULL
<	NULL
0.7	NULL
43	NULL
+	NULL
6.4	NULL
Immune	NULL
serum	NULL
+	NULL
£	NULL
.	NULL

chaffeensis	NULL
736	NULL
+	NULL
105	NULL
2,445	NULL
+	NULL
125	NULL
``	NULL
Cytokine	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
capture	NULL
ELISA	NULL
.	NULL

The	NULL
detection	NULL
limits	NULL
of	NULL
IL-6	NULL
and	NULL
TNF-a	NULL
were	NULL
0.7	NULL
and	NULL
4.4	NULL
pg/ml	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
means	NULL
*	NULL
standard	NULL
deviations	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

Vou	NULL
.	NULL

65	NULL
,	NULL
1997	NULL
CYTOKINE	NULL
INDUCTION	NULL
BY	NULL
E.	NULL
CHAFFEENSIS	NULL
AND	NULL
ANTIBODY	NULL
-	NULL
2895	NULL
A	NULL
-	NULL
Antiserum	NULL
+	NULL
Antiserum	NULL
E	NULL
a	NULL
¥	NULL
U	NULL
.	NULL

.	NULL

&	NULL
-	NULL
p65/p50	NULL
®	NULL
a	NULL
_	NULL
-	NULL
p50/p50	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
480	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
480	NULL
(	NULL
min	NULL
)	NULL
Duration	NULL
of	NULL
infection	NULL
B	NULL
C	NULL
30	NULL
'	NULL
<	NULL
=	NULL
hi	NULL
C	NULL
--	NULL
-	NULL
Antiserum	NULL
wo	NULL
Supershift	NULL
+	NULL
Antiserum	NULL
2	NULL
.	NULL

H	NULL
|-	NULL
p6S/p50	NULL
a	NULL
7	NULL
©	NULL
-	NULL
oo	NULL
|-	NULL
<	NULL
=	NULL
p50/p50	NULL
€	NULL
ke	NULL
]	NULL
E	NULL
C	NULL
6	NULL
S	NULL
6	NULL
&	NULL
10	NULL
I	NULL
3	NULL
PP	NULL
P=	NULL
``	NULL
~	NULL
A	NULL
io	NULL
<	NULL
=	NULL
Free	NULL
Probe	NULL
Z	NULL
p	NULL
LCB	NULL
(	NULL
C|	NULL
0	NULL
15	NULL
30	NULL
_	NULL
60	NULL
120	NULL
240	NULL
-	NULL
480	NULL
Duration	NULL
of	NULL
infection	NULL
(	NULL
min	NULL
)	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
£	NULL
.	NULL

chaffeensis	NULL
.	NULL

(	NULL
A	NULL
)	NULL
THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
host	NULL
cell-free	NULL
E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
dog	NULL
anti-F.	NULL
chaffeensis	NULL
serum	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
levels	NULL
of	NULL
active	NULL
NF-xB	NULL
were	NULL
assessed	NULL
in	NULL
EMSAs	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

These	NULL
autoradiograms	NULL
are	NULL
from	NULL
one	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
p65/p50	NULL
,	NULL
p50/p50	NULL
,	NULL
and	NULL
free	NULL
probe	NULL
are	NULL
marked	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
gels	NULL
used	NULL
for	NULL
panel	NULL
A	NULL
were	NULL
dried	NULL
onto	NULL
3MM	NULL
papers	NULL
,	NULL
and	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
PhosphorImager	NULL
.	NULL

Levels	NULL
of	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p65/p50	NULL
)	NULL
were	NULL
corrected	NULL
against	NULL
the	NULL
0-h	NULL
value	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
THP-1	NULL
cells	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
medium	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
£	NULL
.	NULL

chaffeensis	NULL
preincubated	NULL
with	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
serum	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
preincubated	NULL
with	NULL
no	NULL
reagents	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
,	NULL
unlabeled	NULL
SP1	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
unlabeled	NULL
NF-xB	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
anti-p50	NULL
antibody	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
or	NULL
anti-p65	NULL
antibody	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Anti-p50	NULL
antibody	NULL
incubated	NULL
with	NULL
radioactive	NULL
NF-xB	NULL
probe	NULL
without	NULL
nuclear	NULL
extract	NULL
was	NULL
included	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

significant	NULL
role	NULL
in	NULL
host	NULL
immune	NULL
defense	NULL
in	NULL
infectious	NULL
diseases	NULL
as	NULL
well	NULL
as	NULL
in	NULL
ehrlichial	NULL
infection	NULL
through	NULL
antibody-dependent	NULL
cell-mediated	NULL
cytotoxicity	NULL
(	NULL
27	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
neutralization	NULL
of	NULL
infection	NULL
(	NULL
28	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
antibody	NULL
in	NULL
proinflammatory	NULL
cytokine	NULL
induction	NULL
in	NULL
infectious	NULL
diseases	NULL
has	NULL
,	NULL
however	NULL
,	NULL
been	NULL
overlooked	NULL
because	NULL
in	NULL
most	NULL
infections	NULL
,	NULL
the	NULL
agent	NULL
(	NULL
virus	NULL
,	NULL
bac-terium	NULL
,	NULL
or	NULL
protozoan	NULL
)	NULL
itself	NULL
causes	NULL
a	NULL
significant	NULL
cytokine	NULL
production	NULL
.	NULL

Our	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
antibody	NULL
complexed	NULL
with	NULL
ehrlichias	NULL
enhances	NULL
proinflammatory	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
through	NULL
the	NULL
Fey	NULL
receptor	NULL
.	NULL

It	NULL
was	NULL
already	NULL
known	NULL
that	NULL
Fc	NULL
receptor	NULL
cross-linking	NULL
leads	NULL
to	NULL
the	NULL
production	NULL
of	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
13	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
26	NULL
,	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
signaling	NULL
mechanism	NULL
of	NULL
cytokine	NULL
production	NULL
by	NULL
Fey	NULL
receptor	NULL
cross-linking	NULL
in	NULL
human	NULL
monocytes	NULL
was	NULL
not	NULL
known	NULL
,	NULL
although	NULL
a	NULL
recent	NULL
report	NULL
showed	NULL
that	NULL
stimulation	NULL
of	NULL
a	NULL
mouse	NULL
macrophage	NULL
cell	NULL
line	NULL
with	NULL
immobilized	NULL
IgG2a	NULL
leads	NULL
to	NULL
NF-kB	NULL
activation	NULL
(	NULL
29	NULL
)	NULL
.	NULL

NF-kB	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
,	NULL
including	NULL
many	NULL
cytokine	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
those	NULL
for	NULL
TNF-	NULL
«	NULL
,	NULL
IL-18	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-8	NULL
.	NULL

NF-	NULL
«	NULL
xB	NULL
becomes	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
viruses	NULL
,	NULL
bacteria	NULL
,	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
and	NULL
PMA	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Several	NULL
recent	NULL
studies	NULL
examined	NULL
the	NULL
time-course	NULL
effects	NULL
of	NULL
these	NULL
stimuli	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
IxB-	NULL
«	NULL
degradation	NULL
.	NULL

In	NULL
THP-1	NULL
2896	NULL
LEE	NULL
AND	NULL
RIKIHISA	NULL
-	NULL
Antiserum	NULL
ene	NULL
»	NULL
e	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
240	NULL
480	NULL
0	NULL
comme	NULL
ment	NULL
Simmer	NULL
<	NULL
page	NULL
Commuu®	NULL
«	NULL
=	NULL
``	NULL
15	NULL
30	NULL
60	NULL
InFECT	NULL
.	NULL

ImnmUN	NULL
.	NULL

+Antiserum	NULL
we	NULL
_	NULL
-	NULL
__	NULL
IkB-a	NULL
-	NULL
-tubulin	NULL
120	NULL
240	NULL
480	NULL
(	NULL
min	NULL
)	NULL
Duration	NULL
of	NULL
infection	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
dog	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
serum	NULL
on	NULL
the	NULL
degradation	NULL
of	NULL
IxB-	NULL
«	NULL
in	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
E.	NULL
chaffeensis	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
host	NULL
cell-free	NULL
E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
dog	NULL
anti-E.	NULL
chaffeensis	NULL
serum	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
levels	NULL
of	NULL
IxB-	NULL
«	NULL
were	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
assays	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
«	NULL
-tubulin	NULL
were	NULL
included	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

cells	NULL
stimulated	NULL
with	NULL
TNF-	NULL
«	NULL
or	NULL
LPS	NULL
,	NULL
IxB-a	NULL
«	NULL
was	NULL
rapidly	NULL
degraded	NULL
,	NULL
but	NULL
after	NULL
1	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
IxB-	NULL
«	NULL
protein	NULL
reappeared	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
U937	NULL
cells	NULL
activated	NULL
by	NULL
TNF-a	NULL
or	NULL
PMA	NULL
plus	NULL
ionomy-cin	NULL
,	NULL
IxB-	NULL
«	NULL
was	NULL
rapidly	NULL
decayed	NULL
within	NULL
10	NULL
min	NULL
but	NULL
reappeared	NULL
at	NULL
between	NULL
20	NULL
and	NULL
40	NULL
min	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
the	NULL
pre-B-cell	NULL
line	NULL
70Z	NULL
%	NULL
/3	NULL
,	NULL
both	NULL
PMA	NULL
and	NULL
IL-1	NULL
caused	NULL
rapid	NULL
decay	NULL
of	NULL
IxB-	NULL
«	NULL
within	NULL
5	NULL
min	NULL
,	NULL
and	NULL
IxB-	NULL
«	NULL
protein	NULL
began	NULL
to	NULL
reappear	NULL
after	NULL
40	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
decay	NULL
of	NULL
IKB-	NULL
«	NULL
coincided	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

In-terestingly	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
the	NULL
degradation	NULL
of	NULL
IxB-	NULL
«	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
chaffeensis	NULL
antibody	NULL
and	NULL
E.	NULL
chaffeensis	NULL
persisted	NULL
longer	NULL
than	NULL
the	NULL
other	NULL
stimulations	NULL
described	NULL
above	NULL
.	NULL

The	NULL
sustained	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
major	NULL
proinflammatory	NULL
cytokines	NULL
by	NULL
anti-	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
and	NULL
E.	NULL
chaffeensis	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
E.	NULL
risficii	NULL
organisms	NULL
induced	NULL
significantly	NULL
lower	NULL
levels	NULL
of	NULL
IL-6	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
prostaglandin	NULL
E	NULL
,	NULL
;	NULL
in	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
than	NULL
Escherichia	NULL
coli	NULL
LPS	NULL
induces	NULL
(	NULL
38	NULL
)	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
IL-1	NULL
B	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
IL-10	NULL
but	NULL
not	NULL
TNF-	NULL
«	NULL
and	NULL
IL-6	NULL
are	NULL
induced	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
THP-1	NULL
cells	NULL
infected	NULL
with	NULL
£	NULL
.	NULL

chaffeensis	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
weak	NULL
proinflammatory	NULL
cytokine	NULL
production	NULL
might	NULL
be	NULL
advantageous	NULL
for	NULL
ehrlichiae	NULL
by	NULL
allowing	NULL
them	NULL
to	NULL
remain	NULL
undetected	NULL
and	NULL
establish	NULL
an	NULL
infection	NULL
;	NULL
however	NULL
,	NULL
once	NULL
the	NULL
host	NULL
manages	NULL
to	NULL
make	NULL
antiehrlichial	NULL
antibodies	NULL
,	NULL
ehrlichiae	NULL
may	NULL
be	NULL
eliminated	NULL
not	NULL
only	NULL
by	NULL
antibody-dependent	NULL
cell-mediated	NULL
cytotoxicity	NULL
and	NULL
neutralization	NULL
but	NULL
also	NULL
by	NULL
inducing	NULL
large	NULL
amounts	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
through	NULL
the	NULL
sustained	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Induction	NULL
of	NULL
cytokines	NULL
by	NULL
LPS	NULL
is	NULL
known	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
10	NULL
,	NULL
18	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
also	NULL
show	NULL
that	NULL
interaction	NULL
of	NULL
the	NULL
complex	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
and	NULL
E.	NULL
chaffeensis	NULL
with	NULL
the	NULL
Foy	NULL
receptor	NULL
activates	NULL
NF-kB	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
mechanisms	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
common	NULL
transcription	NULL
factor	NULL
by	NULL
two	NULL
different	NULL
receptors	NULL
have	NULL
not	NULL
been	NULL
documented	NULL
,	NULL
several	NULL
research	NULL
groups	NULL
recently	NULL
reported	NULL
that	NULL
LPS	NULL
induces	NULL
activation	NULL
of	NULL
several	NULL
protein	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
MAPK	NULL
)	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
39	NULL
)	NULL
.	NULL

A	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
inhibits	NULL
LPS-induced	NULL
expression	NULL
of	NULL
IL-1	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
herbimycin	NULL
A	NULL
inhibits	NULL
LPS-induced	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
formation	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphoma	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

MAPK	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
through	NULL
the	NULL
FeyRI	NULL
receptor	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
the	NULL
CD14	NULL
receptor	NULL
and	NULL
the	NULL
Fey	NULL
receptor	NULL
may	NULL
have	NULL
a	NULL
common	NULL
upstream	NULL
path-way	NULL
,	NULL
such	NULL
as	NULL
MAPK	NULL
activation	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
.	NULL

E.	NULL
chaffeensis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
immune	NULL
serum	NULL
can	NULL
induce	NULL
NF-	NULL
«	NULL
xB	NULL
translocation	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
some	NULL
pathogenic	NULL
bacteria	NULL
,	NULL
cell	NULL
wall	NULL
components	NULL
other	NULL
than	NULL
LPS	NULL
promote	NULL
NF-kB	NULL
activation	NULL
in	NULL
a	NULL
monocytic	NULL
or	NULL
macrophage	NULL
cell	NULL
line	NULL
.	NULL

For	NULL
example	NULL
,	NULL
lipoarabinomannans	NULL
from	NULL
different	NULL
strains	NULL
of	NULL
My	NULL
cobacterium	NULL
tuberculosis	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
differentially	NULL
stimulate	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
in	NULL
murine	NULL
macrophages	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Treponema	NULL
pallidum	NULL
and	NULL
Borrelia	NULL
burgdorferi	NULL
lipoproteins	NULL
were	NULL
shown	NULL
to	NULL
induce	NULL
both	NULL
NF-kB	NULL
activation	NULL
and	NULL
cytokine	NULL
production	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
induction	NULL
pathway	NULL
was	NULL
proposed	NULL
to	NULL
be	NULL
distinct	NULL
from	NULL
the	NULL
CD14-dependent	NULL
pathway	NULL
employed	NULL
by	NULL
LPS	NULL
,	NULL
since	NULL
transfection	NULL
of	NULL
a	NULL
CD14-negative	NULL
pre-B-cell	NULL
line	NULL
with	NULL
the	NULL
human	NULL
CD14	NULL
gene	NULL
imparted	NULL
responsiveness	NULL
to	NULL
LPS	NULL
but	NULL
not	NULL
to	NULL
the	NULL
lipopeptides	NULL
of	NULL
7.	NULL
pallidum	NULL
and	NULL
B.	NULL
burgdorferi	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
receptor	NULL
(	NULL
s	NULL
)	NULL
for	NULL
Ehrlichia	NULL
organisms	NULL
has	NULL
not	NULL
been	NULL
identified	NULL
yet	NULL
,	NULL
our	NULL
previous	NULL
results	NULL
showed	NULL
that	NULL
E.	NULL
chaffeensis-mediated	NULL
IL-1B	NULL
induction	NULL
in	NULL
THP-1	NULL
cells	NULL
does	NULL
not	NULL
involve	NULL
CD14	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Data	NULL
from	NULL
the	NULL
present	NULL
study	NULL
suggest	NULL
that	NULL
both	NULL
the	NULL
ehrlichial	NULL
receptor	NULL
and	NULL
the	NULL
Foy	NULL
receptor	NULL
are	NULL
able	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
but	NULL
that	NULL
signals	NULL
mediated	NULL
by	NULL
the	NULL
ehrlichial	NULL
receptor	NULL
produce	NULL
a	NULL
different	NULL
kinetics	NULL
of	NULL
NF-kB	NULL
activation	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
activation	NULL
that	NULL
is	NULL
much	NULL
weaker	NULL
and	NULL
shorter	NULL
than	NULL
that	NULL
mediated	NULL
by	NULL
the	NULL
Foy	NULL
receptor	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
secreted	NULL
proinflammatory	NULL
cytokines	NULL
induced	NULL
by	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
and	NULL
E.	NULL
chaffeensis	NULL
in	NULL
THP-1	NULL
cells	NULL
were	NULL
comparable	NULL
to	NULL
those	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-£	NULL
.	NULL

chaffeensis	NULL
antibody	NULL
the	NULL
effect	NULL
of	NULL
E.	NULL
chaffeensis	NULL
on	NULL
the	NULL
host	NULL
can	NULL
be	NULL
as	NULL
detrimental	NULL
as	NULL
endotoxic	NULL
shock	NULL
.	NULL

This	NULL
generation	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
may	NULL
cause	NULL
temporary	NULL
damage	NULL
in	NULL
the	NULL
host	NULL
but	NULL
concurrently	NULL
contribute	NULL
to	NULL
antiehrlichial	NULL
mechanisms	NULL
by	NULL
activating	NULL
protective	NULL
immune	NULL
responses	NULL
against	NULL
ehrlichiae	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
show	NULL
that	NULL
the	NULL
antibody	NULL
against	NULL
ehrlichiae	NULL
has	NULL
an	NULL
additional	NULL
significant	NULL
role	NULL
in	NULL
immune	NULL
protection	NULL
and	NULL
pathology	NULL
in	NULL
ehrlichial	NULL
infection	NULL
.	NULL

ACKNOWLEDGMENT	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grant	NULL
RO1AI33123	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Anderson	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
J.	NULL
E.	NULL
Dawson	NULL
,	NULL
D.	NULL
C.	NULL
Jones	NULL
,	NULL
and	NULL
K.	NULL
E.	NULL
Wilson	NULL
.	NULL

1991	NULL
.	NULL

Efrlichia	NULL
chaffeensis	NULL
,	NULL
a	NULL
new	NULL
species	NULL
associated	NULL
with	NULL
human	NULL
ehrlichiosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

29:2838-2842	NULL
.	NULL

2	NULL
.	NULL

Anderson	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
K.	NULL
G.	NULL
Sims	NULL
,	NULL
J.	NULL
G.	NULL
Olson	NULL
,	NULL
J.	NULL
E.	NULL
Childs	NULL
,	NULL
J.	NULL
F.	NULL
Piesman	NULL
,	NULL
C.	NULL
M.	NULL
Happ	NULL
,	NULL
G.	NULL
O.	NULL
Maupin	NULL
,	NULL
and	NULL
B.	NULL
J	NULL
.	NULL

B.	NULL
Johnson	NULL
.	NULL

1993	NULL
.	NULL

Amblyomma	NULL
americanum	NULL
:	NULL
a	NULL
potential	NULL
vector	NULL
of	NULL
human	NULL
ehrlichiosis	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Trop	NULL
.	NULL

Med	NULL
.	NULL

Hyg	NULL
.	NULL

49:239-244	NULL
.	NULL

3	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540-546	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179	NULL
.	NULL

5	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

The	NULL
NF-xB	NULL
and	NULL
IxB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-681	NULL
.	NULL

6	NULL
.	NULL

Barnewall	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Y.	NULL
Rikihisa	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Lee	NULL
.	NULL

1997	NULL
.	NULL

Efrlichia	NULL
chaffeensis	NULL
inclusions	NULL
are	NULL
endosomes	NULL
which	NULL
occur	NULL
early	NULL
in	NULL
infection	NULL
and	NULL
which	NULL
selectively	NULL
accumulate	NULL
transferrin	NULL
receptor	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

65:1455-1461	NULL
.	NULL

7	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB-e.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Vou	NULL
.	NULL

65	NULL
,	NULL
1997	NULL
8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Taffet	NULL
.	NULL

1995	NULL
.	NULL

Lipoarabinomannans	NULL
derived	NULL
from	NULL
different	NULL
strains	NULL
of	NULL
Mycobacterium	NULL
tuberculosis	NULL
differentially	NULL
stimulate	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
KBF1	NULL
in	NULL
murine	NULL
macrophages	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

63:1960-1968.	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Bio-chem	NULL
.	NULL

162:156-159	NULL
.	NULL

Cogswell	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
M.	NULL
M.	NULL
Godleyski	NULL
,	NULL
G.	NULL
B	NULL
.	NULL

Wisely	NULL
,	NULL
W.	NULL
C.	NULL
Clay	NULL
,	NULL
L.	NULL
M.	NULL
Leesnitzer	NULL
,	NULL
J.	NULL
P.	NULL
Ways	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Gray	NULL
.	NULL

1994	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
regulates	NULL
IL-16	NULL
transcription	NULL
through	NULL
a	NULL
consensus	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
and	NULL
a	NULL
nonconsensus	NULL
CRE-like	NULL
site	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:712-723	NULL
.	NULL

Dawson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
B.	NULL
E.	NULL
Anderson	NULL
,	NULL
D.	NULL
B.	NULL
Fishbein	NULL
,	NULL
J.	NULL
L.	NULL
Sanchez	NULL
,	NULL
C.	NULL
S.	NULL
Gold-smith	NULL
,	NULL
K.	NULL
H.	NULL
Wilson	NULL
,	NULL
and	NULL
C.	NULL
W.	NULL
Duntley	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
Ehrlichia	NULL
sp	NULL
.	NULL

from	NULL
a	NULL
patient	NULL
diagnosed	NULL
with	NULL
human	NULL
ehrlichiosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

29:2741-2745	NULL
.	NULL

Dawson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
D.	NULL
B.	NULL
Fishbein	NULL
,	NULL
T.	NULL
R.	NULL
Eng	NULL
,	NULL
M.	NULL
A.	NULL
Redus	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Diagnosis	NULL
of	NULL
human	NULL
ehrlichiosis	NULL
with	NULL
the	NULL
indirect	NULL
fluorescent	NULL
antibody	NULL
test	NULL
:	NULL
kinetics	NULL
and	NULL
specificity	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

162:91-95	NULL
.	NULL

Debets	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

Van	NULL
der	NULL
Linden	NULL
,	NULL
I.	NULL
E.	NULL
M.	NULL
Dieteren	NULL
,	NULL
J.	NULL
F.	NULL
M.	NULL
Leeuwenberg	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Buurman	NULL
.	NULL

1988	NULL
.	NULL

Fe-receptor	NULL
cross-linking	NULL
induces	NULL
rapid	NULL
secretion	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
cachectin	NULL
)	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:1197-1201	NULL
.	NULL

Dumler	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Bakken	NULL
.	NULL

1995	NULL
.	NULL

Ebrlichial	NULL
diseases	NULL
of	NULL
humans	NULL
:	NULL
emerging	NULL
tick-borne	NULL
infections	NULL
.	NULL

Clin	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

20:1102-1110	NULL
.	NULL

Durden	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
H.	NULL
M.	NULL
Kim	NULL
,	NULL
B.	NULL
Calore	NULL
,	NULL
and	NULL
Y.	NULL
Liu	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
FoyRI	NULL
receptor	NULL
signals	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
Ack	NULL
and	NULL
MAP	NULL
kinase	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
:	NULL
4039-4047	NULL
.	NULL

Fishbein	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.	NULL
E.	NULL
Dawson	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Robinson	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
chrlichiosis	NULL
in	NULL
the	NULL
United	NULL
States	NULL
,	NULL
1985-1990	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

120:736-743	NULL
.	NULL

Geng	NULL
,	NULL
Y.	NULL
,	NULL
B.	NULL
Zhang	NULL
,	NULL
and	NULL
M.	NULL
Lotz	NULL
.	NULL

1993	NULL
.	NULL

Protein	NULL
tyrosine	NULL
kinase	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
lipopolysaccharide	NULL
induction	NULL
of	NULL
cytokines	NULL
in	NULL
human	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:6692-6700	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
C.	NULL
Doyle	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9769-9773	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben-Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxB-	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Iqbal	NULL
,	NULL
Z.	NULL
,	NULL
W.	NULL
Chaichanasiriwithaya	NULL
,	NULL
and	NULL
Y.	NULL
Rikihisa	NULL
.	NULL

1994	NULL
.	NULL

Comparison	NULL
of	NULL
PCR	NULL
with	NULL
other	NULL
tests	NULL
for	NULL
early	NULL
diagnosis	NULL
of	NULL
canine	NULL
ehrlichiosis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

32:1658-1662	NULL
.	NULL

Krutmann	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Kimmbauer	NULL
,	NULL
A.	NULL
Kock	NULL
,	NULL
T.	NULL
Schwarz	NULL
,	NULL
E.	NULL
Schopf	NULL
,	NULL
L.	NULL
T.	NULL
May	NULL
,	NULL
P.	NULL
B.	NULL
Sehgal	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Luger	NULL
.	NULL

1990	NULL
.	NULL

Cross-linking	NULL
Fc	NULL
receptors	NULL
on	NULL
monocytes	NULL
triggers	NULL
IL-6	NULL
production	NULL
:	NULL
role	NULL
in	NULL
anti-CD3-induced	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:1337-1342	NULL
.	NULL

Lee	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
and	NULL
Y.	NULL
Rikihisa	NULL
.	NULL

1996	NULL
.	NULL

Absence	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
expression	NULL
but	NULL
the	NULL
presence	NULL
of	NULL
IL-1B	NULL
,	NULL
IL-8	NULL
,	NULL
IL-10	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
exposed	NULL
to	NULL
viable	NULL
or	NULL
killed	NULL
Ehrlichia	NULL
chaffeensis	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

64:4211-4219	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-B	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327-2334	NULL
.	NULL

Mahon	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
J.	NULL
O'Neill	NULL
.	NULL

1995	NULL
.	NULL

Studies	NULL
into	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
Editor	NULL
:	NULL
S.	NULL
H.	NULL
E.	NULL
Kaufmann	NULL
CYTOKINE	NULL
INDUCTION	NULL
BY	NULL
E.	NULL
CHAFFEENSIS	NULL
AND	NULL
ANTIBODY	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

2897	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
T	NULL
lympho-cytes	NULL
:	NULL
evidence	NULL
for	NULL
covalent	NULL
modification	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:28557-28564	NULL
.	NULL

Marsh	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
J.	NULL
E.	NULL
Gadek	NULL
,	NULL
G.	NULL
C.	NULL
Kindt	NULL
,	NULL
S.	NULL
A.	NULL
Moore	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Wewers	NULL
.	NULL

1995	NULL
.	NULL

Monocyte	NULL
Fey	NULL
receptor	NULL
cross-linking	NULL
induces	NULL
IL-8	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:3161-3167	NULL
.	NULL

Marsh	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
H.	NULL
A.	NULL
Pope	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Wewers	NULL
.	NULL

1994	NULL
.	NULL

Foy	NULL
receptor	NULL
cross-linking	NULL
down-regulates	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
and	NULL
induces	NULL
IL-1	NULL
$	NULL
in	NULL
mono-nuclear	NULL
phagocytes	NULL
stimulated	NULL
with	NULL
endotoxin	NULL
or	NULL
Staphylococcus	NULL
aureus	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:4604-4611	NULL
.	NULL

Messick	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Y.	NULL
Rikihisa	NULL
.	NULL

1992	NULL
.	NULL

Presence	NULL
of	NULL
parasite	NULL
antigen	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
P388D	NULL
,	NULL
cells	NULL
infected	NULL
with	NULL
Ehrlichia	NULL
risticii	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

60	NULL
:	NULL
3079-3086	NULL
.	NULL

Messick	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Y.	NULL
Rikihisa	NULL
.	NULL

1994	NULL
.	NULL

Inhibition	NULL
of	NULL
binding	NULL
,	NULL
entry	NULL
,	NULL
or	NULL
intracellular	NULL
proliferation	NULL
of	NULL
EArlichia	NULL
risticii	NULL
in	NULL
P388D	NULL
;	NULL
cells	NULL
by	NULL
anti-E.	NULL
risficii	NULL
serum	NULL
,	NULL
immunoglobulin	NULL
G	NULL
,	NULL
or	NULL
Fab	NULL
fragments	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:3156-3161	NULL
.	NULL

Muroi	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Muroi	NULL
,	NULL
and	NULL
T.	NULL
Suzuki	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
immobilized	NULL
IgG2a	NULL
to	NULL
Fey2a	NULL
receptor	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30561-30568	NULL
.	NULL

Norgard	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
L.	NULL
L.	NULL
Arndt	NULL
,	NULL
D.	NULL
R.	NULL
Akins	NULL
,	NULL
L.	NULL
L.	NULL
Curetty	NULL
,	NULL
D.	NULL
A.	NULL
Harrich	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Radolf	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
monocytic	NULL
cells	NULL
by	NULL
Treponema	NULL
pallidum	NULL
and	NULL
Borrelia	NULL
burgdorferi	NULL
lipoproteins	NULL
and	NULL
synthetic	NULL
lipopeptides	NULL
proceeds	NULL
via	NULL
a	NULL
pathway	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
lipopolysaccharide	NULL
but	NULL
involves	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

64:3845-3852	NULL
.	NULL

Polat	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
J.	NULL
Laufer	NULL
,	NULL
I.	NULL
Fabian	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Passwell	NULL
.	NULL

1993	NULL
.	NULL

Cross-linking	NULL
of	NULL
monocyte	NULL
plasma	NULL
membrane	NULL
Fea	NULL
,	NULL
Foy	NULL
or	NULL
mannose	NULL
receptors	NULL
induces	NULL
TNF	NULL
production	NULL
.	NULL

Immunology	NULL
80:287-292	NULL
.	NULL

Rikihisa	NULL
,	NULL
Y	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
tribe	NULL
and	NULL
ehrlichial	NULL
diseases	NULL
.	NULL

Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

4286-308	NULL
.	NULL

Rikihisa	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
A.	NULL
Ewing	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Fox	NULL
.	NULL

1994	NULL
.	NULL

Western	NULL
immunoblot	NULL
analysis	NULL
of	NULL
Ehrlichia	NULL
chaffeensis	NULL
,	NULL
E.	NULL
canis	NULL
,	NULL
or	NULL
E.	NULL
ewingii	NULL
infections	NULL
in	NULL
dogs	NULL
and	NULL
humans	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Microbiol	NULL
.	NULL

32:2107-2112	NULL
.	NULL

Rikihisa	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
I.	NULL
Pretzman	NULL
,	NULL
G.	NULL
C.	NULL
Johnson	NULL
,	NULL
S.	NULL
M.	NULL
Reed	NULL
,	NULL
S.	NULL
Yamamoto	NULL
,	NULL
and	NULL
F.	NULL
Andrews	NULL
.	NULL

1988	NULL
.	NULL

Clinical	NULL
,	NULL
histopathological	NULL
,	NULL
and	NULL
immunological	NULL
responses	NULL
of	NULL
ponies	NULL
to	NULL
Ehrlichia	NULL
sennetsu	NULL
and	NULL
subsequent	NULL
Ehrlichia	NULL
risticit	NULL
challenge	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

56:2960-2966	NULL
.	NULL

Rikihisa	NULL
,	NULL
Y.	NULL
,	NULL
R.	NULL
Wada	NULL
,	NULL
S.	NULL
M.	NULL
Reed	NULL
,	NULL
and	NULL
S.	NULL
Yamamoto	NULL
.	NULL

1993	NULL
.	NULL

Development	NULL
of	NULL
neutralizing	NULL
antibodies	NULL
in	NULL
horses	NULL
infected	NULL
with	NULL
Ehrlichia	NULL
risticii	NULL
.	NULL

Vet	NULL
.	NULL

Microbiol	NULL
.	NULL

36:139-147	NULL
.	NULL

Scheinman	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
A.	NULL
K.	NULL
Lofquist	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

Role	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
IxBa	NULL
in	NULL
mediation	NULL
of	NULL
immunosuppres-sion	NULL
by	NULL
glucocorticoids	NULL
.	NULL

Science	NULL
270:283-286	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octomer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini-extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Van	NULL
Heeckeren	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Y.	NULL
Rikihisa	NULL
,	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
and	NULL
R.	NULL
Fertel	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
,	NULL
interleukin-1	NULL
«	NULL
,	NULL
interleukin-6	NULL
,	NULL
and	NULL
prostaglandin	NULL
E	NULL
;	NULL
production	NULL
in	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
infected	NULL
with	NULL
Ehrlichia	NULL
risticii	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

61:4333-4337	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
J.	NULL
S.	NULL
Sanghera	NULL
,	NULL
K.	NULL
Lemke	NULL
,	NULL
A.	NULL
L.	NULL
DeFranco	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Pelech	NULL
.	NULL

1992	NULL
.	NULL

Bacterial	NULL
lipopolysaccharide	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
in	NULL
macrophages	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:14955-14962	NULL
.	NULL

